Oxford Properties expands biomanufacturing real estate platform with $125m purchase

Oxford Properties Group has purchased a life sciences asset at 92 Crowley Drive in Marlborough, Mass., and executed a long-term leaseback.

The asset is a 120,000-square-foot state-of-the-art biomanufacturing facility under construction and near completion in the Boston life sciences submarket. As part of a real estate transaction with Resilience, a leading technology-focused biomanufacturing company dedicated to broadening access to complex medicines, Oxford will acquire the building and lease the property back to Resilience for up to 30 years. This deal structure raises proceeds for Resilience while allowing it to conduct its day-to-day business operations with full use of the facility.

The acquisition grows Oxford's existing North American cGMP portfolio to 1.4 million square feet, with an additional development pipeline of more than 1 million square feet. The transaction highlights Oxford's deep conviction in biomanufacturing as an integral part of the growth of it